Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 10.55
-0.53 (-4.78%)
Jan 30, 2026, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.57 billion as of January 30, 2026. Its market cap has decreased by -58.62% in one year.
Market Cap
3.57B
Enterprise Value
3.90B
Revenue
1.01B
Ranking
n/a
PE Ratio
162.21
Stock Price
10.55
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.57B, an increase of 2,250.86%. That is a compound annual growth rate of 46.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 3.75B | -1.07% |
| Dec 31, 2025 | 3.79B | -53.94% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 3.47B |
| Neuren Pharmaceuticals | 2.21B |
| Clarity Pharmaceuticals | 1.29B |
| PYC Therapeutics | 968.21M |
| Opthea | 738.77M |
| Immutep | 648.44M |
| Clinuvel Pharmaceuticals | 608.43M |
| Racura Oncology | 442.50M |